AU2664999A - Human channel-related molecules - Google Patents
Human channel-related moleculesInfo
- Publication number
- AU2664999A AU2664999A AU26649/99A AU2664999A AU2664999A AU 2664999 A AU2664999 A AU 2664999A AU 26649/99 A AU26649/99 A AU 26649/99A AU 2664999 A AU2664999 A AU 2664999A AU 2664999 A AU2664999 A AU 2664999A
- Authority
- AU
- Australia
- Prior art keywords
- related molecules
- human channel
- human
- channel
- molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3074798A | 1998-02-25 | 1998-02-25 | |
US09030747 | 1998-02-25 | ||
PCT/US1999/002739 WO1999043807A2 (en) | 1998-02-25 | 1999-02-08 | Human channel-related molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2664999A true AU2664999A (en) | 1999-09-15 |
Family
ID=21855815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU26649/99A Abandoned AU2664999A (en) | 1998-02-25 | 1999-02-08 | Human channel-related molecules |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1056853A2 (en) |
JP (1) | JP2002504368A (en) |
AU (1) | AU2664999A (en) |
CA (1) | CA2321667A1 (en) |
WO (1) | WO1999043807A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10054378A1 (en) * | 2000-10-27 | 2002-05-02 | Mannesmann Ag | Procedure for collecting user fees |
WO2008013816A2 (en) * | 2006-07-24 | 2008-01-31 | Thallion Pharmaceuticals, Incorporated | Tat-051 and methods of assessing and treating cancer |
-
1999
- 1999-02-08 EP EP99906827A patent/EP1056853A2/en not_active Withdrawn
- 1999-02-08 AU AU26649/99A patent/AU2664999A/en not_active Abandoned
- 1999-02-08 WO PCT/US1999/002739 patent/WO1999043807A2/en not_active Application Discontinuation
- 1999-02-08 CA CA002321667A patent/CA2321667A1/en not_active Abandoned
- 1999-02-08 JP JP2000533547A patent/JP2002504368A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1999043807A3 (en) | 1999-12-16 |
EP1056853A2 (en) | 2000-12-06 |
CA2321667A1 (en) | 1999-09-02 |
WO1999043807A2 (en) | 1999-09-02 |
JP2002504368A (en) | 2002-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3485999A (en) | Neo-tryptophan | |
AU9392998A (en) | Pack-a-pillow | |
AU5970699A (en) | Use | |
AU3437799A (en) | City-car | |
AU3522399A (en) | Carvedilol-galenics | |
AU2587399A (en) | Human transport-associated molecules | |
AU3253699A (en) | Myxochelines | |
AU5407599A (en) | Sphingolipid-desaturase | |
AU3668499A (en) | Human receptor molecules | |
AU8363398A (en) | Capotasto | |
AU2609599A (en) | Sensor-coupling | |
AU2227999A (en) | Human ependymin | |
AU3204999A (en) | Futureball | |
AU2069199A (en) | Codelets | |
AU2664999A (en) | Human channel-related molecules | |
AU1055399A (en) | Rollerboard | |
AU2202100A (en) | Human brainiac-5 | |
AU2591099A (en) | Human proteinase molecules | |
AU5223199A (en) | Bathtub-bathseat | |
AU3347599A (en) | Aeromobile | |
AU9347498A (en) | Imidazotriazolopyrimidines | |
AU2840799A (en) | 1-phosphanorbornadienes | |
AU3819799A (en) | Methoximinomethyloxathiazines | |
AU2875299A (en) | Convenience apparatus | |
AU9218098A (en) | Exocyclic-phosphoethanolamines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |